• About
  • Meet The Team
  • Privacy Policy
Friday, January 22, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

BioNTech (NASDAQ: BNTX) And Pfizer Starts Rolling Submission For COVID-19 Vaccine Candidate

by Hasnain R
October 6, 2020
in Featured
Share on FacebookShare on Twitter

BioNTech SE (NASDAQ: BNTX) and Pfizer, Inc. (NYSE: PFE) has announced today that they have started the rolling submission to the European Medicines Agency (EMA) to get approval for the COVID-19 vaccine candidate BNT162b2. European Medicines Agency (EMA) took the decision of review after seeing the promising preliminary results from pre-clinical and early clinical studies in adults.

The preclinical study disclosed that BNT162b2 triggers the production of neutralizing antibodies and TH-1 dominant CD4+ and CD8+ T cells that target SARS-CoV-2, the virus which caused the COVID-19 disease. The study proved that the combination of antibody and T cell are important tools against the novel coronavirus.

Pfizer and BioNTech have disclosed that they are planning to work closely with the EMA’s Committee for Medicinal Products for Human Use (CHMP) to finalize the rolling review process to enable the final Marketing Authorization Application (MAA). In rolling review, CHMP has started evaluating data generated in pre-clinical trials.

The term “rolling review” means that the regulatory authority has begun evaluating the first batch of data on the vaccine. In the rolling review of BNT162b2, the European Medicines Agency (EMA) will evaluate the real-time data which the company gathered after giving doses to patients in different trials. Instead of submitting all that data at once, it is better to start the rolling review so that the company will be able to know where its vaccine candidate stands.

Shares of BioNTech (NASDAQ: BNTX) traded up 6.49% as it gained +5.24 at $85.94 during the trading session of Tuesday. In the past 52-weeks of trading, this company’s stock has fluctuated between the low range of $12.52 and a high range of $105.00. It has moved up 586.15% from its 52-weeks low and moved down -18.15% from its 52-weeks high. This company market capitalization has remained high, hitting $18.96 billion at the time of writing.

On the other hand, Pfizer Inc. (NYSE: PFE) shares were trading down 0.20% as it lost -0.08 during at the time of writing on Tuesday. Pfizer Inc. share price went from a low point around $27.88 to briefly over $ in p40.97ast 52 weeks, though shares have since pulled back to $36.67. PFE market cap has remained high, hitting $204.16 Billion at the time of writing.

The BNT162b2 vaccine candidate is based on the proprietary mRNA technology of BioNTech. It is supported by Pfizer’s global vaccine development and manufacturing capabilities. BioNTech aimed to develop a potential vaccine at this period of uncertainty where COVID-19 is spreading all around the world.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: BioNTech SEBNT162b2COVID19EMAEuropean Medicines AgencyNASDAQ: BNTXNYSE: PFEPFE stockPfizer IncRolling Review

Related Posts

Tesla Inc (NASDAQ:TSLA) Stock Is Soaring. Here’s Why.
Featured

Jaguar Health (JAGX) Closes its $6M Promissory Notes, What’s Next for JAGX Stock?

January 21, 2021
Top 3 Big Data Stocks for long-term Investment
Featured

Top 3 Big Data Stocks for long-term Investment

January 21, 2021
TG Therapeutics (NASDAQ: TGTX) Ublituximab Receives Fast Track Designation In US
Featured

Adamis Pharmaceuticals Corp (ADMP) shares slide 14% as traders take profits

January 21, 2021
Rekor Systems Inc [REKR] Is Just Getting Started on Gains
Featured

Gevo Stock in a dump mode following $350 million offerings, but buoyant in long-term

January 20, 2021
Tesla Inc. (NASDAQ: TSLA) Reportedly Discuss Nickel Supply Deal With Top Miner BHP
Featured

Alibaba (BABA) Stock comes to life after Jack Ma reappears; The potential prospect of BABA this year

January 20, 2021
Is Twilio (NYSE: TWLO) Stock A Buy?
Featured

All Hail Streaming King Netflix Inc. (NFLX)

January 20, 2021
Next Post
Top 20 Banking Industry Stocks For October 2020

Top 20 Banking Industry Stocks For October 2020

Early Morning Vibes: The 4 Best Stocks To Buy Now

Blonder Tongue Receives U.S. Patent Grant For DMM Series Of Products
by Shan Zee
January 14, 2021
0

American stock markets ended trading largely in the green zone on January 13. The S&P 500 index improved to 3810...

Read more

Early Morning Vibes: The 4 Best Stocks To Buy Now

9 Trending Stocks in Travel Services Industry That Can Be A Good Bets
by Shan Zee
January 20, 2021
0

On January 19, American stock indexes finished trading in the green zone. The S&P 500 Index rose 0.81% to 3799...

Read more

Early Morning Vibes: Top 4 Stocks To Watch Right Now

Why Tesla Inc (NASDAQ: TSLA) Stock Might Be A Great Pick?
by Shan Zee
January 19, 2021
0

For Martin Luther King Day, the U.S. treasuries were closed yesterday. In the meantime, on Wednesday, the Americans are waiting...

Read more

Early Morning Vibes: 4 Stocks We Like for Friday

by Shan Zee
January 15, 2021
0

On January 14, the American stock indices closed in the red. The S&P 500 index dropped 0.38% to 3796 points,...

Read more

Early Morning Vibes: 4 Stocks We Like for Thursday

Energy Focus (NASDAQ: EFOI) Introduces Portfolio Of Germicidal UV-C Disinfection Products
by Hasnain R
January 21, 2021
0

On January 20, American stock markets closed at new all-time highs. The S&P 500 index rose 1.39% to 3852 points,...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.